Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

Early Alert: Angiographic Catheter Issue from Boston Scientific

28 August 2026 · By · Wire by Fusion42

Published

28 August 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at fda.gov →

◆ Verified

Fusion42 · 28 August 2026 · Fusion42 review

Boston Scientific has recalled its Imager II Angiographic Catheters due to a manufacturing defect causing reduced stabilizing agents in catheter tips, increasing risk of tip degradation and detachment, with two serious injuries reported in the US.

This Wire brief sits within Fusion42's coverage of Medtech, and 3 sources have reported it between 28 Aug 2026 and 31 Aug 2026.

◆ ◆ The Wire takeaway

You must act quickly if you supply or use angiographic catheters in the US, as Boston Scientific’s recall opens a gap for safer alternatives or service support. Your customers now expect flawless product reliability and compliance, making quick inventory checks and returns critical.

◆ Coverage

3 sources · first reported 28 Aug 2026 · latest 31 Aug 2026

◆ Related on Wire

◆ Topics

Medtechmedical-devicerecallcatheter-issueFDABoston-Scientific